Is galectin-3 a useful biomarker in stratifying the risk of heart failure in diabetes?

被引：0
作者：
Cuspidi, Cesare [1 ]
Gherbesi, Elisa [2 ]
Faggiano, Andrea [2 ,3 ]
机构：
[1] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Cardiothorac Vasc Dis, Milan, Italy
[3] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
来源：
JOURNAL OF CLINICAL ULTRASOUND | 2023年 / 51卷 / 09期
关键词：
ejection fraction; galectin-3; heart failure; type; 2; diabetes;
D O I：
10.1002/jcu.23570
中图分类号：
O42 [声学];
学科分类号：
070206 ; 082403 ;
摘要：
引用
收藏
页码：1436 / 1438
页数：3
相关论文
共 18 条
  • [1] Impact of diabetes on the predictive value of heart failure biomarkers
    Alonso, Nuria
    Lupon, Josep
    Barallat, Jaume
    de Antonio, Marta
    Domingo, Mar
    Zamora, Elisabet
    Moliner, Pedro
    Galan, Amparo
    Santesmases, Javier
    Pastor, Cruz
    Mauricio, Didac
    Bayes-Genis, Antoni
    [J]. CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [2] Targeting galectin-3 in inflammatory and fibrotic diseases
    Bouffette, Selena
    Botez, Iuliana
    De Ceuninck, Frederic
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (08) : 519 - 531
  • [3] Galectin-3 and Hypertensive Heart Disease
    Cuspidi, Cesare
    Tadic, Marijana
    Sala, Carla
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (06) : 503 - 505
  • [4] Effect of diabetes mellitus on association between galectin-3 and H2FPEF score in patients with unexplained dyspnea and a preserved left ventricular ejection fraction
    Dogdu, Orhan
    Karasu, Mehdi
    Karaca, Yuecel
    Harman, Murat
    [J]. JOURNAL OF CLINICAL ULTRASOUND, 2023, 51 (09) : 1429 - 1435
  • [5] Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
    Ho, Jennifer E.
    Liu, Chunyu
    Lyass, Asya
    Courchesne, Paul
    Pencina, Michael J.
    Vasan, Ramachandran S.
    Larson, Martin G.
    Levy, Daniel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (14) : 1249 - 1256
  • [6] Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort
    Jagodzinski, Annika
    Havulinna, Aki S.
    Appelbaum, Sebastian
    Zeller, Tanja
    Jousilahti, Pekka
    Skytte-Johanssen, Silke
    Hughes, Maria F.
    Blankenberg, Stefan
    Salomaa, Veikko
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 192 : 33 - 39
  • [7] Gaiectin-3 as a Potential Prognostic Biomarker for COVID-19 Disease: A Case-Control Study
    Karsli, Emre
    Metin, Damla Anabarli
    Canacik, Omer
    Sabirli, Ramazan
    Kaymaz, Buse
    Kurt, Ozgur
    Koseler, Aylin
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [8] Lebedev Denis A, 2021, J Diabetes Res, V2021, P9589185, DOI 10.1155/2021/9589185
  • [9] How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
    Pieske, Burkert
    Tschoepe, Carsten
    de Boer, Rudolf A.
    Fraser, Alan G.
    Anker, Stefan D.
    Donal, Erwan
    Edelmann, Frank
    Fu, Michael
    Guazzi, Marco
    Lam, Carolyn S. P.
    Lancellotti, Patrizio
    Melenovsky, Vojtech
    Morris, Daniel A.
    Nagel, Eike
    Pieske-Kraigher, Elisabeth
    Ponikowski, Piotr
    Solomon, Scott D.
    Vasan, Ramachandran S.
    Rutten, Frans H.
    Voors, Adriaan A.
    Ruschitzka, Frank
    Paulus, Walter J.
    Seferovic, Petar
    Filippatos, Gerasimos
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (40) : 3297 - 3317
  • [10] Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea
    Reddy, Yogesh N., V
    Kaye, David M.
    Handoko, M. Louis
    van de Bovenkamp, Arno A.
    Tedford, Ryan J.
    Keck, Carson
    Andersen, Mads J.
    Sharma, Kavita
    Trivedi, Rishi K.
    Carter, Rickey E.
    Obokata, Masaru
    Verbrugge, Frederik H.
    Redfield, Margaret M.
    Borlaug, Barry A.
    [J]. JAMA CARDIOLOGY, 2022, 7 (09) : 891 - 899
12